Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

A major international study has found that heart patients, particularly seniors, may benefit more from newer blood-thinning ...

The coronary stents market has become a vital segment within the broader cardiovascular healthcare industry. With the rising prevalence of coronary artery diseases and growing awareness of ...

In patients undergoing chronic total occlusion (CTO) percutaneous coronary intervention (PCI), stenting demonstrated improved ...

Taking low-dose aspirin can help reduce your risk of heart attack and stroke if you have cardiovascular disease, according to ...

Orchestra BioMed holds two best-in-class medical device therapies targeting large markets. Find out why OBIO stock is a Buy.

For most investors, how much a stock's price changes over time is important. This factor can impact your investment portfolio as well as help you compare investment results across sectors and ...

Giving a P2Y12 inhibitor anti-clotting drug to patients with coronary artery disease is associated with lower rates of ...

Understanding calcified coronary artery disease, its risk factors, symptoms, diagnosis, treatment, and prevention for a ...

The following seven stocks are all "strong buys" at five or more Wall Street firms, and have zero sell ratings at present.

This week, a number of companies, big and small, shared updates on their cardiovascular technology innovations at EuroPCR 2025 in Paris.

One of the most common signs of coronary artery disease is chest pain, also known as angina. This pain can feel like pressure ...